Survey of the association between polymorphisms of CTLA-4 exon 1 49 A/G genes with rheumatoid arthritis in Iran.
Mahin LashgariSanaz Keshavarz ShahbazAmir JavadiMehdi SahmaniMaryam KhalajiSeyed Ahmad RasoulinejadFarshad ForoughiPublished in: Journal of immunoassay & immunochemistry (2022)
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), which suppresses T cell proliferation, is a promising candidate for the susceptibility genes to rheumatic arthritis diseases (RA). This study aims to examine the association between the polymorphisms of the CTLA-4 exon 1(+ 49) genes with RA in the Qazvin city of Iran population. The polymerase chain reaction of genomic DNA-restriction fragment length polymorphism (PCR-RFLP) was applied to genotype the CTLA-4 exon 1(+ 49) polymorphisms in 105 RA patients and 90 control subjects. Laboratory diagnostic tests were also measured for RA and control groups. Our results did not demonstrate a significant difference in allele and genotype frequencies of the CTLA-4 exon 1(+ 49) between RA patients and the control group (p < .0001). There was no significant difference in age at onset, CRP, RF value in patients with RA according to the CTLA-4 polymorphisms; just anti-CCP showed a significant difference. Our data declared that polymorphisms of CTLA-4 exon 1(+ 49) genes are not correlated with RA susceptibility and its clinical and paraclinical manifestations.
Keyphrases
- rheumatoid arthritis
- disease activity
- ankylosing spondylitis
- end stage renal disease
- ejection fraction
- cell proliferation
- genome wide
- interstitial lung disease
- newly diagnosed
- chronic kidney disease
- bioinformatics analysis
- systemic lupus erythematosus
- machine learning
- dna methylation
- cross sectional
- gene expression
- signaling pathway
- electronic health record
- copy number
- idiopathic pulmonary fibrosis
- anti inflammatory
- patient reported
- data analysis
- circulating tumor cells